
Entrada Therapeutics (TRDA) Market Capitalization Overview
Market Cap: $288.07M as of Jun 13, 2025
$288.07M
Past Month-$20.12M (6.53%)
As of Jun 13, 2025, Entrada Therapeutics (TRDA) has a market capitalization of $288.07M. Over the past 30 days, its market cap has decreased by -10.06%, while in the last 12 months, it has decreased by -55.48%.
Market capitalization represents the total value of Entrada Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Entrada Therapeutics (TRDA) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Entrada Therapeutics (TRDA) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Entrada Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Entrada Therapeutics (TRDA) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Entrada Therapeutics (TRDA) helps investors assess the company's size and compare it with competitors for better investment decisions.
Entrada Therapeutics (TRDA) Market Cap & Key Trends
See Entrada Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Entrada Therapeutics (TRDA)
Order type
Buy in
Order amount
Est. shares
0 shares
Entrada Therapeutics (TRDA) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $308.95M | -10.06% |
May 1, 2025 | $343.48M | +4.30% |
Apr 1, 2025 | $329.33M | -22.68% |
Mar 3, 2025 | $425.95M | -14.61% |
Feb 3, 2025 | $498.81M | -23.65% |
Jan 2, 2025 | $653.36M | -14.07% |
Entrada Therapeutics (TRDA) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $288.07M | -55.48% |
2024 | $646.99M | +28.60% |
2023 | $503.11M | +18.79% |
2022 | $423.52M | -12.62% |
2021 | $484.71M | — |
FAQs About Entrada Therapeutics (TRDA) Market Cap
As of Jun 13, 2025, the market capitalization of Entrada Therapeutics (TRDA) is $288.07M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Entrada Therapeutics’s market capitalization has decreased by -6.53%, changing from $308.19M to $288.07M as of Jun 13, 2025.
In the last 3 months, Entrada Therapeutics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Entrada Therapeutics’s market capitalization increased from $503.11M in January to $646.99M in December, reflecting a 28.6% change.
In the past five years, Entrada Therapeutics (TRDA) has had a compound annual growth rate (CAGR) of 7.49% in market capitalization. This means its market cap has grown at an average rate of 7.49% per year.